I say risk is less in that a respectable company in MNK has done their DD and are still buying qcor, thus anymore outlandish claims by shorts will have less of an effect on the average investor, of course they had no to little effect on the savvy qcor vets here, but im sure they did on the average joe.
and yes, always good to be ready with powder especially after qcor eps. that said, I do think odds are less shortie will push back hard since the merger news, not saying they wont, but risk is less.
yes not technically free, but low risk and again we are comparing whether to buy mnk or qcor here.
disagree saram, the market is not even placing any value on synergies of the two ( note: mnk price has not increased since the merger news) so even deal doesn't go through ( again odds are very low) then why would the price of qcor fall on that news alone - geez qcor is in 77s and would be here with our eps run up even without the merger news
that said and yes I do agree, if deal doesn't go through, then qcor more exposed to BS short tactics but I think one can then decide then if they want to continue to hold qcor at that time but I don't see some large drop in qcor if the deal doesn't go through, then again, with as we all have learned with qcor anything is possible
it is medbox - I found it please ignore
oh , check out tweed ( twd) on Canadian market)
going to be the main supplier of medical cannibus to Canadians
huge market and potential
loaded more at 1.7 two days ago
$170M ex cash for a company with 1 phase 3, 2 phase 2 and abstral
buy here, come back at year end and u will a happy camper
yep as I suspected and wrote about yesterday
even with merger , MMs still manipping qcor for opex - good lord
ya good plan, buy today , next week should rise with eps 5-8 trading dys away